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Fas-associated death domain (FADD) is an adaptor protein
that is required for the transmission of the death signal from
lethal receptors of the tumor necrosis factor superfamily.
FADD contains a death domain (DD) and a death effector
domain (DED). As death receptors contribute to renal tubular
injury and tubular cell FADD increases in acute renal failure,
we have studied the function of FADD in tubular epithelium.
FADD expression was studied in kidney samples from mice.
In order to study the contribution of FADD to renal tubular
cell survival, FADD or FADD-DD were overexpressed in
murine tubular epithelium. FADD is expressed in renal
tubules of the healthy kidney. Both FADD and FADD-DD
induce apoptosis in primary cultures of murine tubular
epithelium and in the murine cortical tubular cell line.
Death induced by FADD-DD has apoptotic morphology, but
differs from death receptor-induced apoptosis in that it is not
blocked by inhibitors of caspases. Neither an inhibitor of
serine proteases nor overexpression of antiapoptotic BclxL
prevented cell death. However, the combination of caspase
and serine protease inhibition was protective. FADD and
FADD-DD overexpression decreased nuclear factor kappa B
activity. These data suggest that FADD has a death regulatory
function in renal tubular cells that is independent of death
receptors. FADD-DD is sufficient to induce apoptosis in these
cells. This information is relevant to understanding the role
of FADD in tubular injury.
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Tubular cells compose most of the mass of the functioning
kidneys. Loss of renal tubular cells characterizes both acute
and chronic renal failure. Acute tubular necrosis is the most
common form of parenchymal acute renal failure. In human
studies, tubular cell death was the best histopathological
correlate of renal dysfunction in acute tubular necrosis, and
apoptosis was the most common form of cell death.1,2
Apoptosis is an active (requires energy to proceed) mode of
cell death under molecular control.3–5 Apoptosis is tightly
regulated by extracellular and intracellular molecules that
provide multiple regulatory and contraregulatory pathways.
These molecules are potential targets for therapeutic inter-
vention. However, the design of appropriate therapeutic
strategies requires a correct understanding of the molecular
regulation of renal cell apoptosis. In this regard, the role
of apoptosis regulatory molecules may vary in a cell type-
and stimulus-specific manner.5
Death receptors are cell-surface sensors that detect the
presence of specific extracellular death signals and trigger
cellular destruction by apoptosis.6 They are characterized
by the presence of a death domain (DD) within their
cytoplasmic region that mediates the interaction with other
DD-containing proteins. Among these receptors, tumor
necrosis factor receptor-1 and Fas (CD95/Apo-1) have been
shown to be involved in renal damage.3,4,7 Lethal cytokines
such as FasL and tumor necrosis factor (TNF) promote
tubular cell death by binding to and activating these
receptors.8–10 In fact, the antagonism or dysfunction of death
receptors protects from acute tubular damage in experi-
mental models.11,12
FADD was described as an adaptor protein that partici-
pates in apoptosis induced by the death receptors Fas, tumor
necrosis factor receptor, and TNF-related apoptosis-inducing
ligand receptor.6,13 FADD contains a DD and a death effector
domain (DED). Through the DD, FADD binds to the DD of
proteins in the death receptor complex. Through the DED,
FADD recruits and activates procaspase-8, which, in turn,
activates other caspases and promotes apoptosis. Inhibition
or absence of caspase-8 prevents death receptor-induced
apoptosis.14–16 The central role of FADD in apoptosis
induced by several death receptors makes it a candidate for
therapeutic intervention.
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FADD-DD is a truncated molecule corresponding to the
DD of FADD. FADD-DD behaves as a FADD antagonist
in some cell systems: the absence of DED prevents the
recruitment of procaspase-8 and, thus, prevents the propaga-
tion of the lethal signal initiated in the death receptor.13,17,18
In the present study, we addressed the therapeutic possi-
bilities of FADD antagonism by FADD-DD in tubular cell
protection. Surprisingly, we found that in renal tubular
cells, the DD of FADD is sufficient to promote a caspase-
independent form of cell death.
RESULTS
Tubular epithelium is the main site of FADD expression
in the murine kidney
FADD expression was studied in different organs. FADD
protein was found in every organ studied, except in the
central nervous system (Figure 1a). Two FADD bands,
approximately 29–30 kDa were detected in several organs,
the kidney differing from the others in the more intense
expression of the faster migrating band (Figure 1b). These
bands correspond in size to previously described murine
FADD.19 The murine proximal tubular cell line, murine
cortical tubular cells (MCT) also expresses FADD (Figure 1a).
Immunohistochemistry showed that in the healthy kidney
FADD is expressed diffusely throughout the tubular epi-
thelium and in vascular smooth muscle cells, but it is absent
from glomeruli (Figure 1c).
FADD or FADD-DD overexpression in cultured tubular
epithelial cells
Given that FADD is expressed in renal tubular epithelial cells,
we studied FADD function in cultured MCT murine tubular
epithelial cells. MCT cells express large amounts of FADD
comparable to the kidney, although they only express the
slower migrating band that is the most abundantly expressed
form of FADD in all the tissues tested (Figure 1a). FADD
or FADD-DD was overexpressed in transient transfection
experiments. FADD-DD is a truncated molecule correspond-
ing to the DD of FADD (Figure 2a). FADD-DD behaves
as a dominant-negative antagonist of death induced by death
receptors.17 Western blot confirmed protein expression of
the transfected constructs (Figure 2b). Transfected cells were
identified by b-galactosidase (b-Gal) staining (Figure 2c) or
immunofluorescence (Figure 2d).
FADD or FADD-DD overexpression induces apoptosis
in renal tubular epithelium
As expected, FADD overexpression induced cell death with
apoptotic morphology in MCT tubular epithelial cells (Figure
2c). Surprisingly, FADD-DD overexpression also induced
tubular cell death with apoptotic morphology in MCT cells
(Figure 2c and d) and in primary cultures of murine renal
tubular epithelial cells (data not shown). A survival assay
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Figure 1 | FADD protein expression in murine tissues and murine
proximal tubular MCT cells. (a) Western blot: two 29–30 kDa bands
are observed in several tissues. (b) Quantification by densitometry
of both FADD bands, normalized for a-tubulin expression. a.d.u.:
arbitrary densitometry units. (c) Tubular epithelium is the main site of
FADD expression in the kidney. Immunohistochemistry: upper panel,
negative control (non-immune immunoglobulin G); lower panel,
anti-FADD.
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Figure 2 | FADD and FADD-DD transfection in tubular epithelium.
(a) Schematic representation of FADD and FADD-DD proteins. DD:
death domain; DED: death effector domain. (b) Expression of FADD
and FADD-DD detected by anti-FLAG antibodies (Western blot).
(c) Typical apoptotic morphology among FADD-DD-transfected
cells (blue cells stained with b-galactosidase). Note the decreased cell
size (arrowheads), indicative of apoptosis, that predominates among
FADD-DD or FADD-transfected cells. Arrows indicate normal cells.
(d) Green pYFP-FADD-DD-expressing cells with apoptotic features
(arrow). An increased number of detached cells were noted among
those transfected with FADD or FADD-DD. Most detached cells in the
supernatant displayed the apoptotic morphology (arrowhead) with
decreased cell size and condensed chromatin.
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confirmed cell death induction by FADD or FADD-DD in
both MCT cells and primary cultures (Figure 3a). FADD-DD
induced cell death is dose-dependent (Figure 3b). FADD-DD
lethality was independent of the vector and construct used to
overexpress the protein (Figure 3c).
Regulation of cell death induced by FADD-DD
Next, the possible molecular mechanisms of cell death induc-
tion by FADD or FADD-DD in renal tubular epithelium were
explored. FADD or FADD-DD overexpression did not result
in changes in FasL or Fas and no caspase-8 activation was
noted in cells transfected with FADD-DD (not shown). Cell
death induced by FADD or FADD-DD in tubular cells was
not prevented by the pancaspase inhibitor zVAD, nor by
a caspase-8 inhibitor (Figure 4a). We had previously shown
that at the concentrations used, zVAD inhibited caspase acti-
vation and caspase-mediated cell death in tubular epithelial
cells.20,21 Serine proteases may participate in cell death
induced by FADD-DD.22 The serine protease inhibitor 4-(2-
aminoethyl)benzenesulfonyl fluoride hydrochloride (AEBSF)
alone did not prevent FADD-DD-induced apoptosis, but
it did protect when associated with zVAD (Figure 4b). BclxL
overexpression was not protective (Figure 4c), despite the
fact that BclxL-overexpressing cells were protected against
apoptosis induced by TNF8 and FasL (Figure 4d).
In order to address which interactions might be impor-
tant for FADD-DD-induced cell death, the effect of different
mutant FADD-DD proteins was studied. An increased cell
death rate was observed in cells which overexpressed FADD-
DD mutants with different patterns of interaction with
death receptor-related DD-containing proteins23 (Figure 5a).
Dose–response experiments were performed with plasmids
representative of the different interaction patterns (Figure
5b). Only FADD-DD mutant V108E was unable to induce
tubular epithelial cell death (Figure 5c).
FADD may influence the activation of the antiapoptotic
transcription factor nuclear factor kappa B (NFkB) in extra-
renal cells.24 In this sense, FADD-DD overexpression decreased
NFkB activation in tubular epithelial cells (Figure 6).
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Figure 3 | Cell death induced by FADD or FADD-DD
overexpression. (a) Quantification of the lethal effect of FADD
and FADD-DD in the MCT proximal tubular epithelial cell line and
primary cultures of murine renal tubular epithelial cells using survival
assays (b-Gal). (b) Dose–response curve using survival assays. Total
amount of DNA was maintained constant. (c) Quantification of the
lethal effect of different vectors and constructs encoding FADD-DD in
MCT cells using survival assays. Mean (s.d.) of three independent
experiments. *Po0.05 vs control vector.
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Figure 4 | Evaluation of possible mechanisms of cell death
induced by FADD or FADD-DD in renal tubular epithelium.
(a) Cell death induced by FADD or FADD-DD is caspase-independent.
Neither the pancaspase inhibitor zVAD (200 mM) nor the caspase-8
inhibitor IETD (200mM) protected from FADD-DD-induced death
(survival assays). *Po0.05 vs prk5 control vector. (b) The serine
protease inhibitor AEBSF did prevent cell death when in combination
with zVAD (survival assays). *Po0.05 vs FADD-DD alone. (c) Cell
death induced by FADD or FADD-DD is not inhibited in cells
stably overexpressing BclxL (survival assays). *Po0.05 vs prk5
control vector. (d) BclxL-overexpressing cells are protected against
FasL-induced apoptosis (flow cytometry). Cells were cultured
with different concentrations of FasL for 24 h in the presence of
interferon-g (300 U/ml), TNF (30 ng/ml), and LPS (10 mg/ml). Mean
(s.d.) of three independent experiments. *Po0.05 vs MCT.
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DISCUSSION
FADD is expressed in renal tubular epithelium, where it
regulates cell death by a caspase-independent pathway. This
pathway can be activated by either full-length FADD or by its
DD. These data may be relevant to the pathogenesis of renal
injury, as FADD expression in tubular epithelium was
increased in the course of acute tubular injury characterized
by tubular cell apoptosis.25,26
FADD is an adaptor protein that participates in signal
transduction from death receptors such as Fas and TNF
receptor.6 Both receptors have been implicated in death of
tubular epithelium,7–10 and FADD could be a mediator of this
lethal pathway. However, the functional analysis of tubular
epithelial cells suggests that FADD may also participate in the
activation of non-death receptor-mediated lethal pathways.
Similar to observations in most other cell types,13,17,18,20
FADD overexpression induces apoptosis in tubular cells. By
contrast, overexpression of FADD-DD does not promote cell
death in most cell types.13,17,18,20 Tubular epithelium clearly
differs from this paradigm. The FADD-DD domain is suffi-
cient to induce apoptosis in renal tubular epithelium. As full-
length FADD, FADD-DD induced caspase-independent,
BclxL-independent tubular cell death in tubular epithelium.
This implicates molecular mechanisms of cell death different
from death receptors: activation of caspase-8 is the first step
in death receptor-mediated cell death and BclxL protects
tubular epithelium from FasL-induced death, as shown
here, and from TNF-induced apoptosis.8 Consistent with
the lack of the DED domain required to activate caspase-8,
no caspase-8 activation was observed in FADD-DD-trans-
fected cells. There are other exceptions to the neutral effect
of FADD-DD on spontaneous cell death. In normal
prostate epithelium, FADD-DD induces a caspase-indepen-
dent, BclxL-independent cell death.23 FADD-DD mutants
with different affinity for DD-containing proteins were lethal
for both tubular and prostate epithelium, and the pattern of
toxicity was shared.23 There was no correlation between cell
death and intensity of interaction with death receptor-related
proteins, suggesting that FADD-DD is not interfering
with death receptor signaling to cause tubular cell death.
The finding of a single base FADD-DD mutant (V108E) that
is not lethal in either cell type further argues against
nonspecific toxicity and may hold clues as to the molecular
interactions involved.27,28 In addition, a serine protease
inhibitor protected prostate and renal cells when combined
with caspase inhibitors.22 Thus, the molecular mechanisms
involved may be similar in prostate and tubular epithelium.
Data presented here are consistent with reports suggesting
a role for FADD in death receptor-independent events. Thus,
mice lacking FADD die in uterus owing to heart failure and
abdominal hemorrhages.29 This phenotype does not corres-
pond to any of the known knockout mice for death receptors.
Proliferation defects and accelerated apoptosis in thymocytes
lacking FADD or overexpressing FADD-DD have been
noted.30–33 Recent reports indicate that FADD interacts with
other proteins, besides death receptors, such as MyD88 and
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Figure 5 | Effect of different FADD-DD mutants on tubular cell
death. The V121N and D175A mutants interact with Fas-DD, the
R117A, A174P, and D175A mutants interact with TRADD, all mutants
interact with receptor-interacting protein (RIP). FADD-DD interacts
with Fas, TNFR-1-associated death domain (TRADD), and P.22 (a) An
increased cell death rate was observed in cells which overexpressed
FADD-DD or any of the mutants. Although there was no correlation
between intensity of interaction and cell death, the single point
FADD-DD mutants V121N and C168stop, not interacting with TRADD,
displayed higher toxicity. Cells were transfected with 5 mg of plasmid.
(b) A dose–response relationship was observed for representative
plasmids. A total of 5 mg of pYFP-FADD-DD plasmid were used.
(c) The V108E FADD-DD mutant was not lethal. It does not bind
Fas, but it does bind TRADD.29 Cells were transfected with 5 mg of
plasmid. Mean (s.d.) of three independent experiments. *Po0.05 vs
pYFP control vector.
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Figure 6 | Overexpression of FADD or FADD-DD decreases NFjB
activation in renal tubular epithelium. NFkB activity was assessed
by cotransfection with an NFkB-Luc reporter vector. Mean (s.d.)
of three independent experiments. *Po0.05 vs prk5 control
vector-transfected cells.
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AnkG190.24,25,34,35 There are examples of promotion of cell
death by mechanisms shared by FADD and FADD-DD.
In this regard, FADD-DD increases FADD-induced death,
but decreases death induced by receptor-interacting protein
in certain cell types.36 Targeted toxins induce apoptosis
in certain tumors by activating FADD or FADD-DD in
a receptor-independent manner.32 Interaction of FADD
or FADD-DD with MyD88 prevents NFkB activation by
toll-like receptors and interleukin-1b, thus contributing to
cell death.24,34,35 In tubular cells, both FADD and FADD-DD
decrease NFkB activation. It is conceivable that inhibition of
NFkB activity might contribute to tubular cell death. NFkB
promotes the transcription of antiapoptotic genes such as
survivin, XIAP, IAP1, IAP2, FLIP, Bcl-2, BclxL, and Bfl-1/
A1.37 In this regard, inhibition of NFkB activation by a
super-repressor IkBa mutant also induced death in tubular
cells (unpublished observation).
Both death receptors and FADD can promote apoptotic
and non-apoptotic forms of cell death. Dead tubular epithe-
lial cells among those transfected with FADD-DD had
apoptotic morphology. However, it is conceivable that
other pathways for cell death may also become activated,
thus explaining the caspase-insensitivity of cell death in
this model. As an example, the glucose metabolite 3,4-DGE
(3,4-di-deoxyglucosone-3-ene) activates caspases and indu-
ced apoptosis in tubular epithelium, but cell death is caspase-
independent and occurs even when caspases are inhibited.38
The nature of the alternative cell death pathways merits
further study. In particular, the autophagy pathway has
recently been shown to be activated by FADD and FADD-DD
in non-renal cells.27
The present findings may further clarify the role of FADD
in regulating tubular epithelial cell number. In certain cell
types, such as prostate and renal epithelium, FADD may
have an antioncogenic function mediated by the DD and
independent of lethal receptors.23 By contrast to normal
prostate epithelium, FADD-DD does not induce apoptosis in
prostate cancer cell lines: the acquisition of resistance to
death induced by the FADD-DD is a feature of this epithelial
tumor.23 Loss of FADD has been noted in epithelial tumors,
including renal cancer.39,40 FADD may also promote cell
death in response to microenvironmental clues in benign
conditions, such as acute renal failure. We have observed
increased FADD in detached cells with apoptotic morphology
within injured tubules in acute renal failure induced by a folic
acid overdose (P Justo et al., unpublished observation).
Interestingly, the size of the FADD molecule that was
upregulated in the tubuli in this model is the same as that
of the FADD molecule expressed by cultured MCT cells.
This observation complements previous reports of increased
tubular cell FADD expression in ischemic acute renal
failure.25,26
In summary, data presented in this paper suggest that
FADD has a death regulatory function in renal tubular
cells that is independent of death receptors. FADD-DD is
sufficient to induce cell death in murine tubular epithelium.
Novel roles of FADD in acute tubular injury and its
physiological regulators should be further explored.
MATERIALS AND METHODS
Cell lines and reagents
MCT murine proximal epithelial cells derived from normal kidney
of SJL mice were obtained from EG Neilson (Vanderbilt Uni-
versity).41 They were cultured in RPMI 1640 (Life Technologies,
Grand Island, NY, USA), 10% heat-inactivated fetal calf serum,
2 mmol/l glutamine, 100 U/ml penicillin, and 100mg/ml strepto-
mycin at 371C in 5% CO2. Establishment of an MCT cell line
constitutively expressing human BclxL or an empty vector has
been previously described.8 MCT-BclxL cells were cultured as MCT
wild-type cells. Primary cultures of murine tubular epithelial cells
were performed according to previously published techniques.9
Where indicated, cells were treated with the pancaspase inhibitor
Z-Val-Ala-DL-Asp-fluoromethylketone (zVAD-fmk) (200mM; Bachem,
Bubendorf, Switzerland), the caspase-8 inhibitor Z-Ile-Glu(OMe)-
Thr-Asp(OMe)-fluoromethylketone (IETD-fmk) (200mM; Calbio-
chem, San Diego, CA, USA) or the serine protease inhibitor AEBSF
(50–100mM; Sigma, St Louis, MO, USA).20,21
Expression vectors
The expression constructs for the control prk5, the wild-type prk5-
FADD, and prk5-FADD-DD (80–205) were generously provided
by DV Goeddel (Tularik Inc., South San Francisco, CA, USA,
now Amgen SF, LLC) and are described elsewhere.17 In these vectors,
FADD and FADD-DD are FLAG-tagged. The pCI-FADD-DD
expression plasmid was constructed cloning in the pCI-neo
mammalian expression vector from Promega (Madison, WI,
USA), and the SalI–NotI FADD-DD fragment from prk5-FADD-
DD. The expression constructs for the control pYFP and pYFP-
FADD-DD (80–208) were generously provided by A Thorburn
(University of Colorado Health Sciences Center, Denver, CO, USA)
and are described elsewhere.23 pYFP-FADD-DD mutants (R117A,
V121N, C168stop, A174P, V108E, and D175A) were a generous gift
from A Thorburn and are described elsewhere.23 pCMVb (b-gal) is a
mammalian expression vector designed for the expression of b-Gal
in mammalian cells from the human cytomegalovirus immediate-
early gene promoter (Clontech, Palo Alto, CA, USA).
Transient transfection
For transient transfection, cells (MCT, MCT BclxL, and primary
cultures) were plated at a density of 8 104 cells/plate in six-well
plates (Costar, Cambridge, MA, USA) with RPMI 1640 (10% fetal
bovine serum) 24 h before transfection. Cells were transfected with
5 mg of plasmid and 1 mg of reporter vector (pCMVb), using
FuGENETM 6 (Roche, Indianapolis, IN, USA) according to the
manufacturer’s protocol.
Survival assays
To provide an objective assessment of cell loss, b-Gal Enzyme Assay
System with reporter lysis buffer (Promega) was used to assay b-Gal
activity in lysates prepared from cells transfected with b-Gal reporter
vector. Cell lysates were prepared 24 h post-transfection according
to the the manufacturer’s protocol, and the absorbance was read at
420 nm with a Microplate Absorbance Reader Anthos 2020 (Anthos
Labtec Instruments, Wals, Austria). Absorbance for the control
vector (empty vector) was considered to be 100% and percentage
survival refers only to the transfected population.
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In order to observe the morphology of b-Gal-transfected cells,
24 h following transfection, cells were fixed with 2% paraformal-
dehyde/0.2% glutaraldehyde in phosphate-buffered saline (5 min,
41C), washed with phosphate-buffered saline twice, and stained
(1 mg/ml X-Gal, 5 mM potassium ferricyanide, 2 mM MgCl2, 0.02%
NP-40, and 0.01% sodium dodecyl sulfate) at room temperature
until cells turn blue.
pYFP-FADD-DD-expressing cells were identified by their expres-
sion of YFP, a fluorescent protein. They were fixed in 4% para-
formaldehyde and nuclei were counterstained with propidium
iodide for morphological studies of cell death.
Flow cytometry was used to quantitate apoptosis in cells stimu-
lated with cytokines. A total of 10 000 cells were seeded in 24-well
plates (Costar, Cambridge, MA, USA) in 10% fetal calf serum RPMI
overnight. Thereafter, they were rested in serum-free medium for
24 h, and different concentrations of crosslinked FasL (Alexis,
Laufelfigen, Switzerland) for 24 h (in the presence of interferon-g
(300 U/ml), TNF (30 ng/ml), and lipopolysaccharide (10 mg/ml))
were added to subconfluent cells.9 For assessment of apoptosis by
flow cytometry, adherent cells were pooled with spontaneously
detached cells and stained in 100 mg/ml propidium iodide, 0.05%
NP-40, 10 mg/ml RNAse A in phosphate-buffered saline and
incubated at 41C for 41 h. This assay permeabilizes the cells and,
thus, it is not based on the known ability of propidium iodide to
enter dead cells. The percentage of apoptotic cells with decreased
DNA staining (A0) was counted as described previously.
9
Assay of caspase-8 activation
Activation of caspase-8 was detected by the CaspGLOWTMRed Active
Caspase-8 Staining Kit (MBL; Naka-ku, Nagoya, Japan). The cells
was transfected with pYFP or pYFP-FADD-DD, and incubated with
or without caspase-8 inhibitor, IETD-fmk (200 mM; Calbiochem).
Cells were assayed by confocal microscopy, 24 h post-transfection
according to the manufacturer’s protocol. pYFP and pYFP-FADD-
DD-expressing cells were identified by their expression of YFP,
a fluorescent protein. Active caspase-8-positive cells had bright
red signals. The percentage of caspase-8-positive cells among
those transfected was calculated. As a positive and negative control,
we used cells treated with TNFa/TWEAK/interferon-g, or TNFa/
TWEAK/interferon-gþ IETD-fmk, respectively. This methodology
showed caspase-8 activation in 55% of cells treated with TNFa/
TWEAK/interferon-g, which dropped to 9% in the presence of
IETD-fmk. TWEAK was used at 100 ng/ml (ALEXIS).
Immunohistochemistry
Kidney samples were obtained from Balb/c mice (IFFA-CREDO,
Barcelona, Spain). Immunohistochemistry was carried out in
paraffin-embedded tissue sections (5mm thick) as described
previously.8 Sections were counterstained with Carazzi’s hematoxy-
lin. Negative controls included incubation with a nonspecific
immunoglobulin of the same isotype as the primary antibody.
Western blot
Western blots were performed as described previously.8 Briefly, cells
were lysed in 50 mmol/l Tris-HCl, 150 mmol/l NaCl, 2 mmol/l
ethylenediamine tetraacetic acid, 2 mmol/l ethyleneglycol tetraace-
tate, 0.2% Triton X-100, 0.3% NP-40, 0.1 mmol/l phenylmethyl-
sulfonyl fluoride, and protein inhibitors. Lysates were separated by
15% sodium dodecyl sulfate-polyacrylamide gel electrophoresis under
reducing conditions. After electrophoresis, samples were transferred
to polyvinylidine difluoride membranes (Millipore, Bedford, MA,
USA), and nonspecific binding sites were blocked with 5% skimmed
milk in phosphate-buffered saline/0.5% (vol/vol) Tween-20. Mem-
branes were incubated overnight at 41C with mouse anti-FADD
monoclonal antibody (1:1000; MBL), mouse anti-FLAG mono-
clonal antibody (1:1000; Chemicon International Inc., Temecula,
CA, USA), or mouse anti-tubulin monoclonal antibody (1:5000;
Sigma St Louis, MO, USA) followed by incubation with horseradish
peroxidase-conjugated anti-mouse immunoglobulin G (1:2000;
Amersham, Aylesbury, UK). Primary antibodies for Fas and
FasL (Santa Cruz Biotechnology, Santa Cruz, CA, USA) were rabbit
polyclonal used at 1:500 dilution.9 Blots were developed with the
enhanced chemiluminescence method following the manufacturer’s
instructions (Amersham, Buckinghamshire, England, UK).
Assessment of NFjB activation
Transient transfection and luciferase assays were used for this
purpose. The pNFkB-Luc reporter vector containing the NFkB
binding site was obtained from Stratagene (La Jolla, CA, USA).
MCT cells (8 104) on six-well plates were transfected with
luciferase plasmid and pRL-TK vector (containing the Renilla
luciferase gene; Promega, Madison, WI, USA) at a 10:1 ratio, by
using the FuGENETM 6 reagent. Cells were cotransfected with
prk5-FADD, prk5-FADD-DD expression vectors, or the control
empty vector (prk5). After 24 h transfection, luciferase activity in
cleared lysates was assayed using a luciferase assay system (Promega)
and a luminometer (Berthold Analytical Instrument, Nashua, NH,
USA). Firefly luciferase activity was normalized for total protein
content and for variations in transfection efficiency (Renilla
activity).
Statistical analysis
Results are expressed as mean7s.d. of three independent experi-
ments. Significance at the Po0.05 level was assessed by non-
parametric Mann–Whitney test for two groups of data and
Kruskal–Wallis for three of more groups by means of the SigmaStat
statistical software (Jandel, San Rafael, CA, USA).
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